Skip to content

The Effect of Video Streaming With Virtual Reality Before Coronary Angiography

Effect of Virtual Reality Video Viewing Before Coronary Angiography on Anxiety, Comfort, and Patient Satisfaction

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06458647
Enrollment
74
Registered
2024-06-13
Start date
2024-03-01
Completion date
2025-03-01
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Comfort, Patient Satisfaction

Brief summary

This study was planned as a randomized controlled experimental study to examine the effects of virtual reality video on anxiety, comfort and patient satisfaction before coronary angiography. Data will be collected using the Descriptive Characteristics Questionnaire, State-Trait Anxiety Inventory, Early Postoperative Comfort Scale, Visual Analog Scale (VAS) for patient satisfaction and pain, Vital Signs Follow-up Form and Complication Follow-up Form.

Detailed description

This study was planned as a randomized controlled experimental study to examine the effects of virtual reality video on anxiety, comfort and patient satisfaction before coronary angiography. Data will be collected using the Descriptive Characteristics Questionnaire, State-Trait Anxiety Inventory, Early Postoperative Comfort Scale, Visual Analog Scale (VAS) for patient satisfaction and pain, Vital Signs Follow-up Form and Complication Follow-up Form. In addition to the standard practices of the clinic, individuals in the intervention group will be shown a video with virtual reality glasses before entering the angiography procedure. Only standard practices of the clinic will be applied to the control group.

Interventions

OTHERVideo Streaming with Virtual Reality

In the study, patients in the intervention group will be watched videos of natural landscapes such as mountains, beaches and waterfalls with virtual reality goggles before the angiography procedure.

Sponsors

TC Erciyes University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Can speak and understand Turkish, * Over 18 years of age, * No previous angiography procedure, * Oriented to place and time, * No psychiatric illness, * Not taking any sedative medication, * No vision and hearing problems, * Patients who volunteered to participate in the study will be included.

Exclusion criteria

* Patients with any pain or chronic pain prior to coronary angiography, * Patients diagnosed with anxiety, * Patients with pacemakers, * Patients requiring emergency angiography, * Patients taking antihistamines and psychiatric drugs, * Patients who did not volunteer to participate in the study, * Patients taking tranquilizers or pain medication up to 5 hours before the angiography procedure were excluded.

Design outcomes

Primary

MeasureTime frameDescription
Anxiety30 minutes after angiographyThis inventory, which consists of a total of 40 items, is analyzed in two separate sections: The first part is the State Anxiety Inventory, which consists of 20 items, and the individual answers this section with his/her current feelings. The second part is the Trait Anxiety Inventory, which also consists of 20 items, and the individual answers this section with the feelings they have felt in the last 7 days.

Secondary

MeasureTime frameDescription
Comfort30 minutes after angiographyThe scale, which is based on the concept of comfort, consists of a total of 24 items, 12 of which question the comfort status of the individual before and after the surgical intervention, 12 of which question positive and 12 of which question negative experiences.
Patient satisfaction30 minutes after angiographyPatients will be asked to rate their satisfaction with the intervention on a 10-point scale.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 23, 2026